RecruitingNCT06559306

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

This recruiting study focuses on depression and currently lists sites or participation links in Argentina, Brazil, Bulgaria, Colombia, Czechia, Italy, Mexico, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Turkey (Türkiye), United States.

DepressionOtherFrom 18 Years to 74 Years

In plain English

Key information made simple

This study exists to understand how the medication Adjunctive holds up over time after the earliest research stage. Researchers are trying to understand whether the medication Adjunctive can improve sleep, daily rhythms, and longer-term stability. For people living with Depression, small gains in stability can make a meaningful difference over time. If the findings are useful, they could help future care become more targeted, practical, and easier to trust. Taking part helps build the evidence that can improve understanding and care for others over time.

What to expect

Your next step

The official record suggests in-person participation through a hospital, with sites including University of Alabama at Birmingham in Birmingham, Chandler Clinical Trials in Chandler, and University of Arizona in Tucson. Participation appears to involve guided sessions or support activities with check-ins on how they fit into daily life. The main fit is usually being able to follow the planned visits or tasks, while common reasons not to take part include major medical issues that could make participation unsuitable and other factors that could make participation unsuitable. This is a later-stage study, which usually means a larger group and a closer look at how well the approach holds up.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record

Interested?

Check my eligibility

Study reference: NCT06559306. Your email is the only field you need to provide here.

In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular visits and structured follow-up.

Requires travel, with in-person participation in Argentina.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com